evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract
18310,GENE_BACKGROUND,,"TMEM127 (transmembrane protein 127) encodes a tumor suppressor protein with three predicted transmembrane domains. In vitro experiments confirm the localization of TMEM127 at the plasma membrane and indicate a tumor-suppressor role through reduction of mTORC1 activity, demonstrated by phosphorylation of the mTOR effector, S6K, upon TMEM127 depletion (PMID: 20923864, 20154675, 21156949). The latter has also been shown in a tissue sample from a patient with pheochromocytoma (PMID: 20923864). Cell line studies suggest that the failure of mutated TMEM127 to inhibit mTORC1 is due to loss of association with the mTOR inhibitor RAB5 (PMID: ). Truncating germline variants in TMEM127, often in concert with loss of heterozygosity at its genomic locus, confer increased risk for pheochromocytoma and paraganglial tumors (PMID: 20923864, 20154675, 21156949, 22541004, 21613359). TMEM127 mutations have also been observed in renal cancer.",,2017-01-18,,55654,TMEM127,transmembrane protein 127,False,ENST00000258439,NM_001193304.2,False,20154675,Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.,Nature genetics,2018-03-01T20:10:00,42,3,229-33,Qin Y et al,doi: 10.1038/ng.533,,0001-03-01,,22541004,Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma.,Clinical endocrinology,2018-11-01T20:12:00,77,5,707-14,Takeichi N et al,doi: 10.1111/j.1365-2265.2012.04421.x,,0001-11-01,,20923864,A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma.,European journal of endocrinology,2018-01-01T20:11:00,164,True,141-5,Burnichon N et al,doi: 10.1530/EJE-10-0758,,0001-01-01,,21156949,Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.,JAMA,2017-12-15T20:10:00,304,23,2611-9,Yao L et al,doi: 10.1001/jama.2010.1830,,0001-12-15,,21613359,Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.,The Journal of clinical endocrinology and metabolism,2018-08-01T20:11:00,96,8,E1279-82,Neumann HP et al,doi: 10.1210/jc.2011-0114,,0001-08-01,
18309,GENE_SUMMARY,,"TMEM127 is a transmembrane protein and tumor suppressor identified in pheochromocytoma and paraganglial tumors, in which hereditary variants are found.",,2017-01-18,,55654,TMEM127,transmembrane protein 127,False,ENST00000258439,NM_001193304.2,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
